Androscoggin Population Estimate
|
Year
|
Value
|
Type
|
|
2024
|
115,272
|
Population
|
|
2023
|
114,477
|
Population
|
|
2022
|
113,454
|
Population
|
|
2021
|
112,733
|
Population
|
|
2020
|
111,178
|
Population
|
|
2019
|
0
|
Population
|
|
2018
|
0
|
Population
|
|
2017
|
0
|
Population
|
|
2016
|
0
|
Population
|
|
2015
|
0
|
Population
|
Androscoggin Total Operating Revenue
|
Year
|
Value
|
Type
|
|
2024
|
608,930,776
|
Amount
|
|
2023
|
608,270,091
|
Amount
|
|
2022
|
566,801,293
|
Amount
|
|
2021
|
574,814,943
|
Amount
|
|
2020
|
505,618,846
|
Amount
|
|
2019
|
573,605,004
|
Amount
|
|
2018
|
527,726,143
|
Amount
|
|
2017
|
531,013,315
|
Amount
|
|
2016
|
515,936,946
|
Amount
|
|
2015
|
486,668,071
|
Amount
|
Androscoggin Total Operating Margin
|
Year
|
Value
|
Type
|
|
2024
|
-126,083,429
|
Amount
|
|
2023
|
-150,202,404
|
Amount
|
|
2022
|
-174,389,152
|
Amount
|
|
2021
|
-112,292,016
|
Amount
|
|
2020
|
-129,457,821
|
Amount
|
|
2019
|
-71,078,738
|
Amount
|
|
2018
|
-77,694,122
|
Amount
|
|
2017
|
-52,499,413
|
Amount
|
|
2016
|
-51,880,707
|
Amount
|
|
2015
|
-45,320,081
|
Amount
|
Androscoggin Net Profit
|
Year
|
Value
|
Type
|
|
2024
|
-34,257,922
|
Amount
|
|
2023
|
-10,423,759
|
Amount
|
|
2022
|
-76,872,483
|
Amount
|
|
2021
|
-26,354,426
|
Amount
|
|
2020
|
-37,478,362
|
Amount
|
|
2019
|
-19,819,613
|
Amount
|
|
2018
|
-37,396,216
|
Amount
|
|
2017
|
-9,642,915
|
Amount
|
|
2016
|
-2,750,470
|
Amount
|
|
2015
|
4,153,267
|
Amount
|
Androscoggin Total Patient Discharges
|
Year
|
Value
|
Type
|
|
2024
|
11,782
|
Discharges
|
|
2023
|
11,302
|
Discharges
|
|
2022
|
11,622
|
Discharges
|
|
2021
|
13,714
|
Discharges
|
|
2020
|
12,890
|
Discharges
|
|
2019
|
14,143
|
Discharges
|
|
2018
|
15,111
|
Discharges
|
|
2017
|
15,210
|
Discharges
|
|
2016
|
15,159
|
Discharges
|
|
2015
|
15,774
|
Discharges
|
Androscoggin Net Fixed Assets
|
Year
|
Value
|
Type
|
|
2024
|
302,051,507
|
Amount
|
|
2023
|
152,338,584
|
Amount
|
|
2022
|
199,384,133
|
Amount
|
|
2021
|
171,953,487
|
Amount
|
|
2020
|
182,155,558
|
Amount
|
|
2019
|
194,709,856
|
Amount
|
|
2018
|
195,486,426
|
Amount
|
|
2017
|
198,818,576
|
Amount
|
|
2016
|
206,375,173
|
Amount
|
|
2015
|
196,211,162
|
Amount
|
Androscoggin Long Term Liabilities
|
Year
|
Value
|
Type
|
|
2024
|
263,677,312
|
Amount
|
|
2023
|
142,582,545
|
Amount
|
|
2022
|
149,620,001
|
Amount
|
|
2021
|
132,105,109
|
Amount
|
|
2020
|
152,462,154
|
Amount
|
|
2019
|
149,375,893
|
Amount
|
|
2018
|
157,339,024
|
Amount
|
|
2017
|
147,975,937
|
Amount
|
|
2016
|
169,084,987
|
Amount
|
|
2015
|
163,548,389
|
Amount
|
Androscoggin Total Beds
|
Year
|
Value
|
Type
|
|
2024
|
267
|
Beds
|
|
2023
|
267
|
Beds
|
|
2022
|
266
|
Beds
|
|
2021
|
296
|
Beds
|
|
2020
|
296
|
Beds
|
|
2019
|
283
|
Beds
|
|
2018
|
303
|
Beds
|
|
2017
|
303
|
Beds
|
|
2016
|
303
|
Beds
|
|
2015
|
303
|
Beds
|